)
Sai Life Sciences (SAILIFE) investor relations material
Sai Life Sciences Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Delivered a strong Q2 FY26 with robust demand and positive momentum across discovery, development, and manufacturing services, supported by global client trust and scientific depth.
Growth strategy centers on scientific depth, technological differentiation, and global scale, with a focus on being a strategic partner for clients and responsible scaling.
Successfully offset biotech funding slowdown with increased engagement from large pharma clients and a robust, diversified client base.
Investments in new modalities, advanced technologies, and capacity expansion are strengthening long-term competitiveness and scientific capabilities.
Board approved unaudited standalone and consolidated financial results for the quarter and six months ended 30 September 2025, with statutory auditor review and unmodified conclusion.
Financial highlights
H1 FY26 revenue was ₹1,034 crore, up 53% year-over-year from H1 FY25; Q2 FY26 revenue reached ₹537 crore, up 36% year-over-year.
EBITDA for H1 FY26 was ₹281 crore, a 101% increase from H1 FY25; Q2 FY26 EBITDA was ₹156 crore with a 29% margin.
PAT for H1 FY26 stood at ₹144 crore; Q2 FY26 PAT was ₹84 crore, up 102% year-over-year.
CapEx for H1 FY26 was ₹248 crore, focused on R&D infrastructure and new technology investments, aligned with a ₹700 crore annual plan.
Consolidated Q2 FY26 revenue was ₹5,374.70 million, net profit was ₹838.44 million; basic EPS (consolidated) for Q2 FY26 was ₹4.01.
Outlook and guidance
Capacity expansion on track to increase installed capacity from 700 KL to 1,150 KL by end of FY27.
Positioned to achieve 15–20% revenue CAGR over 3–5 years and 28–30% EBITDA margins in the next 2–3 years.
Focus remains on improving asset productivity, optimizing working capital, and strengthening margins.
Management and auditors confirm compliance with accounting standards and regulatory requirements, with no material misstatements identified.
Next Sai Life Sciences earnings date
Next Sai Life Sciences earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)